Add The Wire As Your Trusted Source
For the best experience, open
https://m.thewire.in
on your mobile browser.
AdvertisementAdvertisement

What Is a Hallucinogen?

What these mind-altering drugs do in our brains.
What these mind-altering drugs do in our brains.
what is a hallucinogen
Magic mushrooms or 'shrooms' have hallucinogenic effects when eaten. Photo: Flickr
Advertisement

The term “drug” applies to all substances that can induce any biological changes in any of our bodies’ functions. But that label doesn’t differentiate at all between the drugs taken to alleviate diseases and those used recreationally.

For some drugs, their purpose and use is obvious to us. Antibiotics, for example, have clear and legal medical benefits, while methamphetamines are illegal and therefore perceived as dangerous.

But many drugs require a more nuanced understanding of the fine line between helpful and harmful. Opioids, for instance, have revolutionized the medical field and provide vital pain relief for those who need it most, but their misuse and addiction potential has also created a nationwide crisis.

Also read: Central Asians Smoked Weed 2,500 Years Ago, Remains at Tomb Suggest

Hallucinogens are an excellent example of this paradox. They are a diverse group of substances collectively defined by their ability to disrupt the ways in which we perceive the world. Though there are many varieties, all act primarily on the brain chemistry involved in that perception. Interestingly, these drugs evoke a wide range of emotions, even among those who are not partaking.

Advertisement

In 1970, President Richard Nixon called Timothy Leary, the Harvard psychologist and proselytiser for LSD, who claimed it would cure all our society’s woes, “the most dangerous man in America.” Despite (or because of) their role in the widespread cultural upheavals of the 1960s, the majority of these drugs were declared illegal and hallucinogenic research and culture was driven underground. Now, these drugs are in the midst of a significant revival, as new research indicates treatment options too successful to keep hidden for a variety of mental illnesses and disorders.

Hallucinogens are capable of influencing the brain through a variety of mechanisms, by which they induce subjective experiences that depend as much on the person taking them as the chemistry of the drug itself.

Advertisement

Also read: Name-Place-Animal-Thing: Of Productivity and LSD

Several similar hallucinogenic substances are grouped together as”dissociatives,” for their ability to separate sensory inputs from perceptions, allowing a user to feel like they have removed themselves from their body, dissociated from their physical form. These trances or “out-of-body” experiences are the effects desired by those taking these drugs recreationally, but they also can be medically useful; dissociative drugs such as ketamine are regularly used as anaesthetics during surgery.

Advertisement

Generally these substances block NMDA receptors, which mediate communication in the brain, resulting in lost connections between the conscious brain and its sensory inputs. Other dissociatives can also be used medically, such as dextromethorphan (DXM), the drug which gives Robitussin its cough-suppressing ability; or they can be used illicitly, such as phencyclidine (PCP).

Advertisement

But the most well-known group of hallucinogens are undoubtedly the psychedelics. The name comes from the Greek for “mind manifesting,” since these drugs are known for expanding the mind and dissolving the ego. This group includes Lysergic Acid Diethylamide (LSD), psilocybin (the active ingredient in magic mushrooms), and mescaline (often from the peyote cactus).

Also read: How Does LSD Induce Short-Term Psychosis but Long-Term Optimism?

For many, psychedelics conjure up images of the tie-dyed 60s, of hippies in San Francisco and at Woodstock who preached peace and love to the soundtrack of The Beatles and the Grateful Dead — and whose hallucinogenic drug use was eventually denounced and criminalised. Lost in the subsequent stigmatisation was the success psychiatrists had seen while treating their patients with psychedelics in conjunction with therapy.

The results were astounding, helping people with diseases from crippling depression to alcoholism, with few to no side effects. Nonetheless, LSD and psilocybin were declared “Schedule I” drugs with no medical value in the Controlled Substances Act (1970), and all public research was embargoed and terminated.

Today, that research is moving back to the forefront. Changing regulations surrounding marijuana and MDMA (“Ecstasy”) are examples of how research can drive legal and cultural evolution — both have shown great success treating disorders like epilepsy and Post-Traumatic Stress Disorder, and social and legal acceptance of both drugs has been growing.

As researchers continue to accumulate evidence of recreational drugs’ safety and efficacy, psychedelics are poised to be the next success story.

This article was first published in Massive Science. Read the original here.

This article went live on June fifteenth, two thousand nineteen, at zero minutes past six in the morning.

The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.

Advertisement
Advertisement
tlbr_img1 Series tlbr_img2 Columns tlbr_img3 Multimedia